About the Authors

Nicholas Murgolo

nicholas.murgolo@merck.com

Affiliation Department of Genetics and Pharmacogenomics, Merck & Co., Inc., Kenilworth, New Jersey, United States of America

Alex G. Therien

Affiliation Exploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, United States of America

Bonnie Howell

Affiliation Department of Infectious Diseases and Vaccines, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Daniel Klein

Affiliation Department of Computational and Structural Chemistry, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Kenneth Koeplinger

Affiliation Department of Pharmacokinetics, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Linda A. Lieberman

Affiliation Exploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, United States of America

Gregory C. Adam

Affiliation Department of Quantitative Biosciences, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Jessica Flynn

Affiliation Department of Infectious Diseases and Vaccines, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Philip McKenna

Affiliation Department of Infectious Diseases and Vaccines, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Gokul Swaminathan

Affiliation Exploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts, United States of America

Daria J. Hazuda

Affiliation Discovery Biology & Translational Medicine, Merck & Co., Inc., West Point, Pennsylvania, United States of America

David B. Olsen

‡ Senior author.

Affiliation Department of Infectious Diseases and Vaccines, Merck & Co., Inc., West Point, Pennsylvania, United States of America

Competing Interests

All authors are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and may own stock or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA.